Alaunos Therapeutics (TCRT) Competitors $2.94 -0.08 (-2.65%) Closing price 08/5/2025 03:59 PM EasternExtended Trading$5.50 +2.56 (+87.07%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TCRT vs. SYBX, MTEX, GELS, BLRX, LPCN, LEXX, COCP, HOTH, NEUP, and EDSAShould you be buying Alaunos Therapeutics stock or one of its competitors? The main competitors of Alaunos Therapeutics include Synlogic (SYBX), Mannatech (MTEX), Gelteq (GELS), BioLineRx (BLRX), Lipocine (LPCN), Lexaria Bioscience (LEXX), Cocrystal Pharma (COCP), Hoth Therapeutics (HOTH), Neuphoria Therapeutics (NEUP), and Edesa Biotech (EDSA). These companies are all part of the "pharmaceutical products" industry. Alaunos Therapeutics vs. Its Competitors Synlogic Mannatech Gelteq BioLineRx Lipocine Lexaria Bioscience Cocrystal Pharma Hoth Therapeutics Neuphoria Therapeutics Edesa Biotech Synlogic (NASDAQ:SYBX) and Alaunos Therapeutics (NASDAQ:TCRT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends and media sentiment. Does the media refer more to SYBX or TCRT? In the previous week, Synlogic's average media sentiment score of 0.00 equaled Alaunos Therapeutics'average media sentiment score. Company Overall Sentiment Synlogic Neutral Alaunos Therapeutics Neutral Do institutionals and insiders hold more shares of SYBX or TCRT? 63.4% of Synlogic shares are held by institutional investors. Comparatively, 27.7% of Alaunos Therapeutics shares are held by institutional investors. 3.0% of Synlogic shares are held by insiders. Comparatively, 16.1% of Alaunos Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is SYBX or TCRT more profitable? Synlogic's return on equity of 10.91% beat Alaunos Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets SynlogicN/A 10.91% 7.47% Alaunos Therapeutics N/A -169.34%-124.28% Which has more risk and volatility, SYBX or TCRT? Synlogic has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500. Comparatively, Alaunos Therapeutics has a beta of -0.81, suggesting that its stock price is 181% less volatile than the S&P 500. Which has preferable valuation & earnings, SYBX or TCRT? Alaunos Therapeutics is trading at a lower price-to-earnings ratio than Synlogic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynlogic$10K1,638.00-$23.36M-$2.51-0.56Alaunos Therapeutics$10K482.16-$4.68M-$2.54-1.16 SummarySynlogic beats Alaunos Therapeutics on 7 of the 9 factors compared between the two stocks. Get Alaunos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TCRT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TCRT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TCRT vs. The Competition Export to ExcelMetricAlaunos TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.95M$2.53B$5.59B$9.53BDividend YieldN/A1.77%4.71%4.14%P/E Ratio-1.169.1628.8923.88Price / Sales482.16717.24448.2598.82Price / CashN/A159.4135.6858.35Price / Book2.285.078.175.60Net Income-$4.68M$31.61M$3.25B$265.26M7 Day Performance2.44%-0.38%1.13%-0.15%1 Month Performance-41.38%5.79%8.23%6.07%1 Year Performance20.49%3.58%29.35%24.21% Alaunos Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCRTAlaunos Therapeutics0.5103 of 5 stars$2.94-2.6%N/A+15.3%$4.95M$10K-1.1640Upcoming EarningsSYBXSynlogic1.0201 of 5 stars$1.54-4.9%N/A-11.9%$18.02M$10K-0.6180Gap DownHigh Trading VolumeMTEXMannatechN/A$9.44+15.1%N/A+14.0%$17.94M$117.87M-94.40250Upcoming EarningsGap DownHigh Trading VolumeGELSGelteqN/A$1.88+2.5%N/AN/A$17.70MN/A0.00N/ABLRXBioLineRx2.1067 of 5 stars$4.13-0.7%$26.00+529.5%-84.8%$17.59M$28.94M-0.4740LPCNLipocine2.6821 of 5 stars$3.27-3.8%$9.00+175.2%-38.2%$17.49M$11.20M-3.2110News CoveragePositive NewsEarnings ReportLEXXLexaria Bioscience2.8538 of 5 stars$0.89-0.7%$4.00+349.9%-74.0%$17.39M$615.92K-1.337COCPCocrystal Pharma2.2304 of 5 stars$1.71-1.2%$6.00+251.1%-5.7%$17.38MN/A-1.0910News CoveragePositive NewsUpcoming EarningsHOTHHoth Therapeutics2.7806 of 5 stars$1.30-0.8%$4.00+207.7%+119.4%$17.17MN/A-1.144News CoverageUpcoming EarningsNEUPNeuphoria Therapeutics1.1979 of 5 stars$8.56-1.5%$21.00+145.3%N/A$16.09M$15.66M0.00N/AEDSAEdesa Biotech1.7436 of 5 stars$2.29-1.7%$5.00+118.3%-53.5%$16.08MN/A-1.4420News CoveragePositive NewsUpcoming Earnings Related Companies and Tools Related Companies Synlogic Alternatives Mannatech Alternatives Gelteq Alternatives BioLineRx Alternatives Lipocine Alternatives Lexaria Bioscience Alternatives Cocrystal Pharma Alternatives Hoth Therapeutics Alternatives Neuphoria Therapeutics Alternatives Edesa Biotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TCRT) was last updated on 8/6/2025 by MarketBeat.com Staff From Our Partners[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alaunos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
